Sumitomo Pharma Co., Ltd. (ADR)
General ticker "SMDPY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $3.0B (TTM average)
Sumitomo Pharma Co., Ltd. (ADR) follows the US Stock Market performance with the rate: 47.6%.
Estimated limits based on current volatility of 0.0%: low 11.45$, high 11.45$
Short-term SMDPY quotes
Long-term SMDPY plot
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | ¥560,035.00MM | ¥555,544.00MM | ¥314,558.00MM |
| Operating Expenses | ¥499,801.00MM | ¥632,523.00MM | ¥668,752.00MM |
| Operating Income | ¥60,234.00MM | ¥-76,979.00MM | ¥-354,194.00MM |
| Non-Operating Income | ¥22,727.00MM | ¥29,059.00MM | ¥31,080.00MM |
| Interest Expense | ¥3,050.00MM | ¥3,159.00MM | ¥4,277.00MM |
| R&D Expense | ¥94,903.00MM | ¥131,858.00MM | ¥112,637.00MM |
| Income(Loss) | ¥82,961.00MM | ¥-47,920.00MM | ¥-323,114.00MM |
| Taxes | ¥42,361.00MM | ¥48,794.00MM | ¥-8,185.00MM |
| Profit(Loss)* | ¥56,413.00MM | ¥-74,512.00MM | ¥-314,969.00MM |
| Stockholders Equity | ¥607,888.00MM | ¥406,749.00MM | ¥156,063.00MM |
| Inventory | ¥99,021.00MM | ¥94,405.00MM | ¥115,350.00MM |
| Assets | ¥1,308,007.00MM | ¥1,134,742.00MM | ¥907,506.00MM |
| Operating Cash Flow | ¥31,239.00MM | ¥11,937.00MM | ¥-241,893.00MM |
| Capital expenditure | ¥13,494.00MM | ¥12,742.00MM | ¥15,730.00MM |
| Investing Cash Flow | ¥-18,278.00MM | ¥52,419.00MM | ¥33,036.00MM |
| Financing Cash Flow | ¥-21,426.00MM | ¥-146,817.00MM | ¥77,851.00MM |
| Earnings Per Share** | ¥141.99 | ¥-187.55 | ¥-792.79 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.